Literature DB >> 10719870

Stereotactic radiosurgery for tentorial dural arteriovenous fistulae draining into the vein of Galen: report of two cases.

M Shin1, H Kurita, M Tago, T Kirino.   

Abstract

OBJECTIVE AND IMPORTANCE: Treatment of tentorial dural arteriovenous fistulae (DAVFs) primarily draining into the vein of Galen remains a therapeutic challenge. We present two cases of ruptured galenic DAVFs that were successfully treated with gamma knife radiosurgery. CLINICAL
PRESENTATION: Patient 1, a 66-year-old woman, experienced a sudden onset of headache and loss of consciousness. Neuroimaging studies revealed intraventricular hemorrhage and a DAVF with aneurysmal dilation of the vein of Galen. The DAVF was supplied by tentorial branches of the right meningohypophyseal artery and bilateral supracerebellar arteries, which drained directly into the vein of Galen. Patient 2, a 64-year-old woman, experienced subarachnoid hemorrhage. Cerebral angiography revealed a galenic DAVF at the falcotentorial junction, which was supplied by bilateral supracerebellar arteries. This patient had an aneurysm at the origin of the left supracerebellar artery. INTERVENTION: Both patients were treated with gamma knife radiosurgery. In each case, the fistula was exclusively targeted and a dose of more than 20 Gy was delivered. Complete obliteration of the fistula was confirmed 27 and 29 months after radiosurgery for Patients 1 and 2, respectively, whereas the normal venous structures of the galenic system were preserved.
CONCLUSION: Gamma knife radiosurgery is an effective treatment modality for DAVFs primarily draining into the vein of Galen. Irradiation doses of more than 20 Gy, strictly limited to the fistulae, seem to be sufficient for successful obliteration of these high-risk vascular lesions, with minimal invasiveness.

Entities:  

Mesh:

Year:  2000        PMID: 10719870     DOI: 10.1097/00006123-200003000-00039

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  8 in total

1.  Bilateral petrous ridge dural arteriovenous malformations treated by a combination of endovascular embolization and surgical excision. A case report.

Authors:  S O Seong; C David; In Sup Choi
Journal:  Interv Neuroradiol       Date:  2006-12-13       Impact factor: 1.610

Review 2.  Radiosurgery for intracranial dural arteriovenous fistulas (DAVFs): a review.

Authors:  Ioannis Loumiotis; Giuseppe Lanzino; David Daniels; Jason Sheehan; Michael Link
Journal:  Neurosurg Rev       Date:  2011-05-17       Impact factor: 3.042

3.  Neurovascular radiosurgery.

Authors:  M Söderman; W Y Guo; B Karlsson; D M Pelz; E Ulfarsson; T Andersson
Journal:  Interv Neuroradiol       Date:  2006-12-13       Impact factor: 1.610

4.  Percutaneous Transvenous Embolization of Intracranial Dural Arteriovenous Fistulas with Detachable Coils and/or in Combination with Onyx.

Authors:  Xianli Lv; Chuhan Jiang; Youxiang Li; Xinjian Yang; Zhongxue Wu
Journal:  Interv Neuroradiol       Date:  2009-01-05       Impact factor: 1.610

5.  Endovascular treatment of high-risk tentorial dural arteriovenous fistulas: clinical outcomes.

Authors:  Chuhan Jiang; Xianli Lv; Youxiang Li; Jingbo Zhang; Zhongxue Wu
Journal:  Neuroradiology       Date:  2008-11-07       Impact factor: 2.804

6.  Tentorial dural fistulas: endovascular management and description of the medial dural-tentorial branch of the superior cerebellar artery.

Authors:  J V Byrne; M Garcia
Journal:  AJNR Am J Neuroradiol       Date:  2013-05-09       Impact factor: 3.825

7.  Surgical management of dural arteriovenous fistulas with transosseous arterial feeders involving the jugular bulb.

Authors:  W Tirakotai; L Benes; C Kappus; U Sure; A Farhoud; S Bien; H Bertalanffy
Journal:  Neurosurg Rev       Date:  2006-11-16       Impact factor: 3.042

8.  Endovascular treatment of vein of Galen dural arteriovenous fistula presenting as dementia.

Authors:  Vikram Huded; Syed Zafer Moeed; Romnesh Desouza; Ravikesh Tripathi; Rithesh Nair
Journal:  Ann Indian Acad Neurol       Date:  2014-10       Impact factor: 1.383

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.